Skip to main content
. 2020 Jul 31;10:12906. doi: 10.1038/s41598-020-69560-4

Table 1.

Baseline characteristics of the participants.

no Ex + placebo Ex + placebo Ex + LCPUFA p
(n = 28) (n = 27) (n = 21)
Age (year)a 67.4 ± 1.0 67.8 ± 0.8 67.1 ± 1.1 0.895
Sex (M/F)b 10/18 9/18 10/11 0.633
BMI (kg/m2)a 22.4 ± 0.5 22.7 ± 0.6 22.7 ± 0.6 0.906
Education (year)a 13.3 ± 0.4 13.7 ± 0.4 13.2 ± 0.6 0.777
MoCA-Ja 22.2 ± 0.6 23.5 ± 0.5 23.5 ± 0.7 0.207
WMS-R LM IIa 13.1 ± 0.8 13.4 ± 1.1 13.4 ± 1.1 0.972
LCPUFA in plasma PL
  ARA (%)a 10.0 ± 0.3 9.5 ± 0.3 9.7 ± 0.4 0.488
  EPA (%)a 2.1 ± 0.2 2.2 ± 0.2 2.1 ± 0.3 0.938
  DHA (%)a 7.6 ± 0.3 7.6 ± 0.3 7.1 ± 0.3 0.447
SMI (kg/m2)a 6.4 ± 0.2 6.2 ± 0.2 6.5 ± 0.2 0.701
Physical activity (METs/day)a 0.9 ± 0.0 0.9 ± 0.0 0.9 ± 0.0 0.800
Step (/day)a 6,716 ± 621 5,935 ± 419 7,807 ± 794 0.115

Mean ± SE. There was no significant difference among the groups in baseline data (aANOVA, bchi-square test). Ex, exercise; BMI, body mass index; MoCA-J, Montreal Cognitive Assessment Japanese version; WMS-R LM II, Wechsler memory scale-revised logical memory II; LCPUFA, long-chain polyunsaturated fatty acid; PL, phospholipids; ARA, arachidonic acid; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; SMI, skeletal muscle mass index.